instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news
These are our top 10 things to watch in the stock market Tuesday
Competition will make weight-loss drugs better, cheaper and bigger | Mint
Eli Lilly and Company (NYSE:LLY) Trading 2.1% Higher - Should You Buy?
Eli Lilly and Company (NYSE:LLY) Shares Up 2.1% – Here’s Why
Weight-loss drugs: A game changer for India’s top pharma companies | Stock Market News
Eli Lilly and Company (NYSE:LLY) Shares Bought by M&T Bank Corp
Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture
Applied Therapeutics CEO Steps Down, Les Funtleyder Appointed As Interim CEO | Markets Insider
Eli Lilly, Avago lead market cap stock movers this Friday By Investing.com
Ozempic parent's stock having worst day since the 1980s as new weight-loss drug disappoints | Morningstar
LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List - December 20, 2024 - Zacks.com
Novo Nordisk's new weight-loss drug works better, but not as well as expected | Morningstar
FDA says Lilly weight loss drug shortage is over after taking a second look
Eli Lilly and Company (NYSE:LLY) Stock Price Down 0.3% – Time to Sell?
Eli Lilly and Company (NYSE:LLY) Trading Down 0.3% – Should You Sell?
Eli Lilly and Company (NYSE:LLY) Shares Down 1.2% - Here's Why
Independent Solutions Wealth Management LLC Buys 49 Shares of Eli Lilly and Company (NYSE:LLY)
Independent Solutions Wealth Management LLC Has $773,000 Position in Eli Lilly and Company (NYSE:LLY)
Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over By Investing.com
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, manufacturing expansion By Investing.com
Eli Lilly and Company (NYSE:LLY) Shares Down 0.2% - Here's What Happened
Stocks reverse lower as bond yields soar — what in the Fed rate cut decision is the cause
Cancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments | Morningstar
Weight loss drugs could help end obesity - but risks remain, WHO says
Eli Lilly and Company (NYSE:LLY) Trading Down 0.3% - Should You Sell?
Eli Lilly Alzheimer’s drug donanemab approved in China By Investing.com
China approves Eli Lilly's Alzheimer's treatment Kisunla By Investing.com
Eli Lilly & Co. and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt By Investing.com
Eli Lilly: Egyptian Drug Authority Approves Insulin Glargine Injection Manufactured By EVA Pharma
Eli Lilly and Company (NYSE:LLY) Stock Price Up 0.2% - Still a Buy?
516 Shares in Eli Lilly and Company (NYSE:LLY) Purchased by SMART Wealth LLC
CHEPLAPHARM acquires Gemzar from Lilly
Eli Lilly's SWOT analysis: stock soars on obesity drug success By Investing.com
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China | The Manila Times
EMA Panel Endorses Lilly's Omvoh for Expanded Use in Crohn's Disease - December 16, 2024 - Zacks.com
Innovent and Eli Lilly to expand commercialisation rights for oncology drug Jaypirca in Mainland China
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China | Morningstar
Innovent and Eli Lilly Expand Collaboration By Investing.com
Eli Lilly and Company (NYSE:LLY) Shares Bought by Kovitz Investment Group Partners LLC
Rep. Greg Landsman Sells Off Shares of Eli Lilly and Company (NYSE:LLY)
Lord Abbett & CO. LLC Has $334.89 Million Position in Eli Lilly and Company (NYSE:LLY)
B. Riley Wealth Advisors Inc. Decreases Holdings in Eli Lilly and Company (NYSE:LLY)
Why Is Eli Lilly and Company (LLY) Among the Best Income Stocks to Buy According to Analysts?
Eli Lilly and Company (NYSE:LLY) Stock Price Down 0.1% - Should You Sell?
DGS Capital Management LLC Grows Position in Eli Lilly and Company (NYSE:LLY)
DGS Capital Management LLC Raises Stake in Eli Lilly and Company (NYSE:LLY)
Garden State Investment Advisory Services LLC Raises Holdings in Eli Lilly and Company (NYSE:LLY)
Old North State Trust LLC Has $6.37 Million Stock Holdings in Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Shares Sold by Old North State Trust LLC
Logan Capital Management Inc. Decreases Stock Position in Eli Lilly and Company (NYSE:LLY)
1ST Source Bank Sells 649 Shares of Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) is Birmingham Capital Management Co. Inc. AL's 3rd Largest Position
Eli Lilly and Company (NYSE:LLY) Stake Lifted by FFG Partners LLC
Retirement Systems of Alabama Trims Holdings in Eli Lilly and Company (NYSE:LLY)
Lilly Gets Positive CHMP Opinion For Omvoh In Crohn's Disease
Oddo BHF Asset Management Sas Makes New Investment in Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Shares Sold by Franklin Resources Inc.
Eli Lilly and Company (NYSE:LLY) Shares Sold by Peapack Gladstone Financial Corp
Eli Lilly and Company (NYSE:LLY) Shares Sold by Synovus Financial Corp
Eli Lilly's Omvoh recommended by CHMP for approval in EU By Investing.com
Eli Lilly and Company (NYSE:LLY) Shares Bought by Sanctuary Advisors LLC
Eli Lilly and Company (NYSE:LLY) Shares Sold by Sfmg LLC
Eli Lilly and Company (NYSE:LLY) Shares Down 0.7% - Here's Why
Optimist Retirement Group LLC Purchases 531 Shares of Eli Lilly and Company (NYSE:LLY)
TCW Group Inc. Sells 275 Shares of Eli Lilly and Company (NYSE:LLY)
Tidal Investments LLC Purchases 8,424 Shares of Eli Lilly and Company (NYSE:LLY)
Blankinship & Foster LLC Invests $78 Million in Eli Lilly and Company (NYSE:LLY)
Destination Wealth Management Acquires 25,472 Shares of Eli Lilly and Company (NYSE:LLY)
Sanctuary Advisors LLC Acquires 20,451 Shares of Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Stock Holdings Cut by Stock Yards Bank & Trust Co.
Eli Lilly and Company (NYSE:LLY) Position Boosted by Chelsea Counsel Co.
SOA Wealth Advisors LLC. Purchases 20 Shares of Eli Lilly and Company (NYSE:LLY)
Q2 EPS Estimate for Eli Lilly and Company Reduced by Analyst
Why Eli Lilly and Company (LLY) Is the Best Safe Stock to Buy According to Analysts?
Eli Lilly and Company (NYSE:LLY) Shares Purchased by Virtu Financial LLC
Analysts Set Eli Lilly and Company (NYSE:LLY) PT at $1,007.94
Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study - December 12, 2024 - Zacks.com
3 Stocks to Keep an Eye on After Dividend Hike Announcement - December 12, 2024 - Zacks.com
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1.2% - Time to Sell?
Jim Cramer Says He Would Prefer Eli Lilly (LLY) Over Regeneron Even at $900
Virtue Capital Management LLC Reduces Stake in Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Shares Acquired by TD Private Client Wealth LLC
Fortem Financial Group LLC Acquires 390 Shares of Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Shares Bought by Wilson & Boucher Capital Management LLC
Eli Lilly and Company (NYSE:LLY) Shares Sold by Hohimer Wealth Management LLC
Bard Financial Services Inc. Sells 2,950 Shares of Eli Lilly and Company (NYSE:LLY)
Lilly Reports Positive Phase 3 EMBER-3 Study Data In Advanced Breast Cancer | Markets Insider
Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer | Morningstar
TD Private Client Wealth LLC Boosts Holdings in Eli Lilly and Company (NYSE:LLY)
Arete Wealth Advisors LLC Reduces Position in Eli Lilly and Company (NYSE:LLY)
Toronto Dominion Bank Sells 130,160 Shares of Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (NYSE:LLY) Earns “Buy” Rating from Bank of America
Will Eli Lilly’s blockbuster obesity drug be available in India in 2025?
Imlunestrant shows promise in advanced breast cancer study By Investing.com